Aripiprazole Monohydrate Impurities | Pharmaffiliates

Aripiprazole Monohydrate and its Impurities

Aripiprazole Monohydrate was approved by FDA (Abilify trade name) for the treatment of schizophrenia; manic and mixed episodes associated with bipolar I disorder; major depressive disorder; irritability associated with autistic disorder; Tourette's disorder and agitation associated with schizophrenia or bipolar mania. Reference standards of Aripiprazole Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for Aripiprazole Monohydrate Impurities
PA 01 3380000

Aripiprazole Monohydrate - API

Aripiprazole Monohydrate


  • Catalogue No.:PA 01 3380000

  • CAS :

    851220-85-4

  • Molecular Formula : C23H29Cl2N3O3

  • Molecular Weight : 466.4